Pulmonary infections imitating lung cancer: clinical presentation and therapeutical approach.

PubWeight™: 1.64‹?› | Rank: Top 3%

🔗 View Article (PMID 22592566)

Published in Ir J Med Sci on May 17, 2012

Authors

M Schweigert1, A Dubecz, M Beron, D Ofner, H J Stein

Author Affiliations

1: Department of General and Thoracic Surgery, Klinikum Nürnberg Nord, Nürnberg, Germany. michael.schweigert@klinikum-nuernberg.de

Articles by these authors

Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg (1998) 4.95

Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg (1998) 4.86

Dating the rise of atmospheric oxygen. Nature (2004) 4.29

Boerhaave's syndrome: analysis of the literature and report of 18 new cases. Dis Esophagus (1997) 3.06

Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility. Am J Gastroenterol (1992) 2.96

Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg (2000) 2.85

Development of Myocardial Necrosis and Absence of Nerve Degeneration in Thiamine Deficiency in Pigs. Am J Pathol (1943) 2.56

Pylorus-preserving versus standard pancreatico-duodenectomy: an analysis of 110 pancreatic and periampullary carcinomas. Br J Surg (1992) 2.54

Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg (2001) 2.49

THE EXCRETION OF SPECIFIC FLUORESCENT SUBSTANCES IN THE URINE IN EXPERIMENTAL NICOTINIC ACID DEFICIENCY. J Clin Invest (1942) 2.39

Transoral access for endoscopic thyroid resection. Surg Endosc (2007) 2.38

Local excision and endoscopic posterior mesorectal resection versus low anterior resection in T1 rectal cancer. Br J Surg (2008) 2.14

Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography. Ann Surg (2001) 2.04

Tracheobronchial lesions following oesophagectomy: prevalence, predisposing factors and outcome. Br J Surg (1998) 1.99

PEEP-induced tricuspid regurgitation. Intensive Care Med (1997) 1.95

Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer. Br J Surg (1998) 1.78

Number of lymph node metastases is significantly associated with survival in patients with radically resected carcinoma of the ampulla of Vater. Br J Surg (1995) 1.77

Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg (1994) 1.75

Stented versus nonstented pancreaticojejunostomy after pancreatoduodenectomy: a prospective study. Ann Surg (1999) 1.60

Computerized identification of pathologic duodenogastric reflux using 24-hour gastric pH monitoring. Ann Surg (1991) 1.58

Sneddon's syndrome. A long-term follow-up of 21 patients. Arch Dermatol (1993) 1.58

Achalasia and esophageal cancer: incidence, prevalence, and prognosis. World J Surg (2001) 1.55

Flexible versus rigid endoscopy for treatment of foreign body impaction in the esophagus. Surg Endosc (2007) 1.54

Boerhaave's syndrome: the man behind the syndrome. Dis Esophagus (1997) 1.53

[Anastomotic leaks in the upper gastrointestinal tract]. Chirurg (2004) 1.53

[Comparison of the quality of life after subtotal and total gastrectomy for stomach carcinoma]. Dtsch Med Wochenschr (1996) 1.50

Enucleation of submucosal tumors of the esophagus: minimally invasive versus open approach. Surg Endosc (2004) 1.46

Citric Acid cycle activity in mitochondria isolated from mung bean hypocotyls. Plant Physiol (1976) 1.46

Duodenoesophageal reflux and the development of esophageal adenocarcinoma in rats. Surgery (1992) 1.38

Composition and concentration of bile acid reflux into the esophagus of patients with gastroesophageal reflux disease. Surgery (1997) 1.37

Micrometastasis and tumor cell microinvolvement of lymph nodes from esophageal squamous cell carcinoma: frequency, associated tumor characteristics, and impact on prognosis. Cancer (1998) 1.35

TROP2 expression as prognostic marker for gastric carcinoma. J Clin Pathol (2008) 1.32

Cervical esophageal perforation with severe mediastinitis due to an impacted dental prosthesis. Dis Esophagus (2002) 1.29

Relationship of a satisfactory outcome to normalization of delayed gastric emptying after Nissen fundoplication. Ann Surg (1989) 1.24

Minimizing the side effects of antireflux surgery. World J Surg (1992) 1.20

Prognostic significance of expression patterns of c-erbB-2, p53, p16INK4A, p27KIP1, cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma: a tissue microarray study. J Clin Pathol (2006) 1.18

Adenocarcinoma of the esophago-gastric junction. Scand J Surg (2006) 1.16

Atrophic variants of dermatofibroma and dermatofibrosarcoma protuberans. Histopathology (1995) 1.15

Classic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance. J Neurosurg (1992) 1.14

Presence and possible significance of immunocytochemically demonstrable metallothionein over-expression in primary invasive ductal carcinoma of the breast. Virchows Arch A Pathol Anat Histopathol (1993) 1.13

Tumor microcirculation evaluated by dynamic magnetic resonance imaging predicts therapy outcome for primary rectal carcinoma. Cancer Res (2001) 1.12

Prognosis and life expectancy in chronic liver disease. Dig Dis Sci (1995) 1.12

Preoperative chemotherapy unmasks underlying Barrett's mucosa in patients with adenocarcinoma of the distal esophagus. Surg Endosc (2002) 1.09

Pneumatosis cystoides intestinalis coli. Surg Endosc (2002) 1.08

Fibrovascular esophageal polyp as a diagnostic challenge. Dis Esophagus (2000) 1.07

Esophageal diverticula and cancer. Dis Esophagus (2011) 1.07

Responders benefit from neoadjuvant radiochemotherapy in esophageal squamous cell carcinoma: results of a prospective phase-II trial. Eur J Surg Oncol (2004) 1.06

Carcinoma of the periampullary region: who benefits from portal vein resection? Am J Surg (1996) 1.05

Role of esophageal body function in gastroesophageal reflux disease: implications for surgical management. J Am Coll Surg (1997) 1.03

Frequency and clinical impact of lymph node micrometastasis and tumor cell microinvolvement in patients with adenocarcinoma of the esophagogastric junction. Cancer (2000) 1.03

Surgical resection for cancer of the cardia. Semin Surg Oncol (1999) 1.02

Deep penetrating dermatofibroma versus dermatofibrosarcoma protuberans. A clinicopathologic comparison. Am J Surg Pathol (1994) 1.02

Immunohistochemically demonstrated metallothionein expression in malignant melanoma. Histopathology (1993) 1.02

The 'angiogenic switch' in the progression from Barrett's metaplasia to esophageal adenocarcinoma. Eur J Surg Oncol (2003) 1.01

Gastric Cancer. Curr Probl Surg (1997) 1.00

Diagnostic value of different PCR assays for the detection of mycobacterial DNA in granulomatous lymphadenopathy. J Pathol (1996) 1.00

Lymphadenectomy for gastric cancer in clinical trials: update. World J Surg (1995) 1.00

Preoperative chemotherapy for stage III-IV gastric carcinoma: feasibility, response and outcome after complete resection. Br J Surg (1995) 1.00

Endoscopic stent insertion for anastomotic leakage following oesophagectomy. Ann R Coll Surg Engl (2013) 0.99

Prognostic value of histobiological factors (malignancy grading and AgNOR content) assessed at the invasive tumour front of oral squamous cell carcinomas. Br J Cancer (1997) 0.99

Lymph-node dissection in squamous cell esophageal cancer -- who benefits? Langenbecks Arch Surg (1999) 0.99

Lymphatic vessel invasion is an independent prognostic factor in patients with a primary resected tumor with esophageal squamous cell carcinoma. Cancer (2001) 0.98

The effect of nephrectomy on the outcome of renal transplantation in patients with polycystic kidney disease. Ann Transplant (1996) 0.97

Problem of proximal third gastric carcinoma. World J Surg (1995) 0.97

Risk analysis in esophageal surgery. Recent Results Cancer Res (2000) 0.97

Lack of EGFR gene mutations in exons 19 and 21 in esophageal (Barrett's) adenocarcinomas. Dis Esophagus (2007) 0.96

Ultrasonographic detection of lymph-node metastases in superficial carcinoma of the esophagus. Endoscopy (1996) 0.96

The prognostic impact of O6-Methylguanine-DNA Methyltransferase (MGMT) promotor hypermethylation in esophageal adenocarcinoma. Int J Cancer (2006) 0.96

Suspected inguinal hernias in pregnancy--handle with care! Hernia (2013) 0.95

Multimodal treatment for squamous cell esophageal cancer. World J Surg (1995) 0.93

Squamous cell carcinoma and Zenker diverticulum. Dis Esophagus (2007) 0.93

Malignant degeneration of Barrett's esophagus: the role of the Ki-67 proliferation fraction, expression of E-cadherin and p53. Dis Esophagus (2004) 0.93

A new technique to define and clarify esophageal motor disorders. Am J Surg (1990) 0.93

COX2 expression, angiogenesis, proliferation and survival in Barrett's cancer. Eur J Surg Oncol (2005) 0.92

The cause of dysphagia in uncomplicated sliding hiatal hernia and its relief by hiatal herniorrhaphy. A roentgenographic, manometric, and clinical study. Ann Surg (1990) 0.92

Oxidative and Phosphorylative Activities of Mitochondria Isolated from Pea Root Tissues. Plant Physiol (1965) 0.91

Prognostic factors in resected primary small bowel tumors. Dig Surg (1998) 0.91

Concentration of refluxed acid and esophageal mucosal injury. Am J Surg (1992) 0.91

Inhibition of store-operated calcium entry contributes to the anti-proliferative effect of non-steroidal anti-inflammatory drugs in human colon cancer cells. Int J Cancer (2001) 0.90

Neoadjuvant therapy for oesophagogastric cancer. Br J Surg (2004) 0.90

New aspects of prognostic factors in adenocarcinomas of the small bowel. Hepatogastroenterology (2001) 0.90

Expression of cyclo-oxygenase 1 and 2, prostaglandin E synthase and transforming growth factor beta1, and their relationship with vascular endothelial growth factors A and C, in primary adenocarcinoma of the small intestine. Br J Surg (2006) 0.89

Does the Incidence of Adenocarcinoma of the Esophagus and Gastric Cardia Continue to Rise in the Twenty-First Century?-a SEER Database Analysis. J Gastrointest Surg (2013) 0.88

Surgical management of pleural empyema in the very elderly. Ann R Coll Surg Engl (2012) 0.88

Assessment of non-acid esophageal reflux: comparison between long-term reflux aspiration test and fiberoptic bilirubin monitoring. Dis Esophagus (1997) 0.88

Gastroesophageal sphincter: a model. Dis Esophagus (1997) 0.88

Synchronous and metachronous carcinomas of the esophagus and head and neck. Dis Esophagus (1997) 0.88

II. Vinzenz Czerny (1842-1915): grand seigneur of oncologic surgery--life, influence, and work of the Second Congress President of the ISS/SIC. International Society of Surgery/Société Internationale de Chirurgie. World J Surg (2000) 0.88

Expandable metal stents versus laser combined with radiotherapy for palliation of unresectable esophageal cancer: a prospective randomized trial. Hepatogastroenterology (2000) 0.88

Guidelines of AgNOR quantitation. Committee on AgNOR Quantitation within the European Society of Pathology. Zentralbl Pathol (1994) 0.87

Standardized demonstration of silver-stained nucleolar organizer regions-associated proteins in archival oral squamous cell carcinomas and adjacent non-neoplastic mucosa. Mod Pathol (1997) 0.86

Intramural esophageal hematoma after cardioversion. Dis Esophagus (1997) 0.86

Neoadjuvant chemotherapy for gastric cancer: update. World J Surg (1995) 0.86

Argyrophilic nucleolar organizer region proteins (Ag-NORs) in human brain tumors: relations with grade of malignancy and proliferation indices. Acta Neuropathol (1990) 0.86

Intravital lectin perfusion analysis of vascular permeability in human micro- and macro- blood vessels. Histochem Cell Biol (2001) 0.85

Standardized AgNOR analysis of the invasive tumour front in oral squamous cell carcinomas. J Pathol (1997) 0.84